Entering text into the input field will update the search result below

Vor Biopharma's acute myeloid leukemia treatment wins FDA Fast Track status

Sep. 09, 2021 8:44 AM ETVor Biopharma Inc. (VOR) StockBy: SA News Team

FDA - Food and Drug Administration text on document above brown envelope and stethoscope. Healthcare or medical concept
syahrir maulana/iStock via Getty Images

  • Vor Biopharma (NASDAQ:VOR) announces that the U.S. FDA has granted Fast Track designation to VOR33, the company’s lead engineered hematopoietic stem cell ((eHSC)) therapeutic candidate for the treatment of acute myeloid leukemia (AML).
  • Fast

Recommended For You

More Trending News

About VOR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VOR--
Vor Biopharma Inc.